F.D. Tattersall

2.6k total citations
30 papers, 2.0k citations indexed

About

F.D. Tattersall is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Surgery. According to data from OpenAlex, F.D. Tattersall has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in F.D. Tattersall's work include Nausea and vomiting management (11 papers), Neuropeptides and Animal Physiology (10 papers) and Anesthesia and Pain Management (7 papers). F.D. Tattersall is often cited by papers focused on Nausea and vomiting management (11 papers), Neuropeptides and Animal Physiology (10 papers) and Anesthesia and Pain Management (7 papers). F.D. Tattersall collaborates with scholars based in United Kingdom, United States and Canada. F.D. Tattersall's co-authors include Richard Hargreaves, Wayne Rycroft, R.J. Naylor, R.G. Hill, B. Costall, A.M. Domeney, Margaret A. Cascieri, Annette Robichaud, Hedaythul Choudhury and D. Euan MacIntyre and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

F.D. Tattersall

30 papers receiving 1.9k citations

Peers

Countries citing papers authored by F.D. Tattersall

Since Specialization

Citations

This map shows the geographic impact of F.D. Tattersall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.D. Tattersall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.D. Tattersall more than expected).

Fields of papers citing papers by F.D. Tattersall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.D. Tattersall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.D. Tattersall. The network helps show where F.D. Tattersall may publish in the future.

Co-authorship network of co-authors of F.D. Tattersall

This figure shows the co-authorship network connecting the top 25 collaborators of F.D. Tattersall. A scholar is included among the top collaborators of F.D. Tattersall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.D. Tattersall. F.D. Tattersall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Gregori J. Morriello, Sander G. Mills, (unknown), Mikhail Reibarkh, Gary G. Chicchi, Julie A. DeMartino, Marc M. Kurtz, Philip R. Davies, (unknown), Song Guo Zheng, Xinchun Tong, Emma Carlson, (unknown), F.D. Tattersall, Alan Wheeldon, Susan Boyce, Neil Collinson, N.M.J. Rupniak, Stephen Moore, Robert J. DeVita	8
2	Gaboxadol, a selective extrasynaptic GABAA agonist, does not generalise to other sleep-enhancing drugs: A rat drug discrimination study 2006 ·Neuropharmacology ·Louise McDonald, (unknown), (unknown), Bindi Sohal, F.D. Tattersall, P.H. Hutson	6
3	An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Gerard R. Dawson, Karen Maubach, Neil Collinson, Mark Cobain, Barry J. Everitt, Angus M. MacLeod, Hedaythul Choudhury, Louise McDonald, Gopalan V. Pillai, Wayne Rycroft, Alesha Smith, Francine Sternfeld, F.D. Tattersall, Keith A. Wafford, David S. Reynolds, Guy R. Seabrook, John Atack	207
4	Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors 2006 ·Neuropharmacology ·Jennifer Li, R.L. Fish, Susan M. Cook, F.D. Tattersall, John Atack	29
5	Detection of gender differences in rat lens proteins using 2‐D‐DIGE 2005 ·PROTEOMICS ·Paul C. Guest, Heather A. Skynner, Kamran Salim, F.D. Tattersall, Michael R. Knowles, John Atack	11
6	Selective, Orally Active γ-Aminobutyric Acid _A α5 Receptor Inverse Agonists as Cognition Enhancers 2004 ·Journal of Medicinal Chemistry ·Francine Sternfeld, Robert W. Carling, Richard A. Jelley, (unknown), Kevin J. Merchant, Kevin W. Moore, Austin J. Reeve, Leslie J. Street, Desmond O’Connor, Bindi Sohal, John Atack, Susan M. Cook, Guy R. Seabrook, Keith A. Wafford, F.D. Tattersall, Neil Collinson, Gerard R. Dawson, José L. Castro, Angus M. MacLeod	92
7	Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists 2003 ·European Journal of Cancer ·Paul J. Hesketh, Simon Van Belle, Matti Aapro, F.D. Tattersall, R.J. Naylor, Richard Hargreaves, A. Carides, Judith K. Evans, Kevin Horgan	208
8	BRAIN PENETRATION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN FERRETS 2003 ·Drug Metabolism and Disposition ·Su-Er W. Huskey, Brian J. Dean, Ray Bakhtiar, Rosa I. Sánchez, F.D. Tattersall, Wayne Rycroft, Richard Hargreaves, Alan P. Watt, Gary G. Chicchi, (unknown), (unknown), Shuet‐Hing Lee Chiu	42
9	PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway 2001 ·Neuropharmacology ·Annette Robichaud, Chantal Savoie, Panagiota B. Stamatiou, F.D. Tattersall, C C Chan	107
10	The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets 2000 ·Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, M. Cumberbatch, G.S. Mason, Spencer J. Tye, David J. Williamson, (unknown), Sander G. Mills, Paul E. Finke, Malcolm MacCoss, Sharon Sadowski, E Ber, Margaret A. Cascieri, R.G. Hill, D. Euan MacIntyre, Richard Hargreaves	120
11	Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret 1999 ·Neuropharmacology ·Annette Robichaud, F.D. Tattersall, Hedaythul Choudhury, Ian W. Rodger	80
12	In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists 1997 ·European Journal of Pharmacology ·N.M.J. Rupniak, F.D. Tattersall, Angela Williams, Wayne Rycroft, Emma Carlson, Margaret A. Cascieri, Sharon Sadowski, Elżbieta Ber, Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Eileen M. Seward, Ian T. Huscroft, Simon N. Owen, Christopher J. Swain, R.G. Hill, Richard Hargreaves	88
13	Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets 1996 ·Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, B. Francis, David Pearce, Kevin J. Merchant, Angus M. MacLeod, T. Ladduwahetty, Linda E. Keown, Christopher J. Swain, R. BAKER, Margaret A. Cascieri, E Ber, Joseph M. Metzger, D. Euan MacIntyre, R.G. Hill, Richard Hargreaves	189
14	Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994 1995 ·Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, (unknown), Margaret A. Cascieri, Reginald Hill, Richard Hargreaves	24
15	Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994 1994 ·Neuropharmacology ·F.D. Tattersall, Wayne Rycroft, R.G. Hill, Richard Hargreaves	75
16	The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex 1994 ·British Journal of Pharmacology ·Mark D. Tricklebank, Linda J. Bristow, Peter H. Hutson, Paul D. Leeson, Michael Rowley, Kay L. Saywell, L. Singh, F.D. Tattersall, (unknown), Brian J. Williams	31
17	The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret 1993 ·European Journal of Pharmacology ·F.D. Tattersall, Wayne Rycroft, Richard Hargreaves, R.G. Hill	88
18	Fluphenazine, ICS 205–930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret 1990 ·Neuropharmacology ·B. Costall, A.M. Domeney, R.J. Naylor, (unknown), John A. Rudd, F.D. Tattersall	38
19	Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors 1989 ·European Journal of Pharmacology ·Colin T. Dourish, A Rückert, F.D. Tattersall, S.D. Iversen	101
20	5-Hydroxytryptamine M-receptor antagonism in the hypothalamus facilitates gastric emptying in the guinea-pig 1986 ·Neuropharmacology ·B. Costall, M.E. Kelly, R.J. Naylor, (unknown), F.D. Tattersall	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact